Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer).
Mycobacterium ulcerans disease, or Buruli ulcer (BU), causes significant morbidity in West Africa. In 233 consecutive, laboratory-confirmed samples from BU patients in Benin whose Mycobacterium bovis BCG scar status was known, 130 children (<15 years old) and 75 adults had a neonatal BCG vaccination scar. Of 130 children with BCG scars, 10 (7.7%) had osteomyelitis, while 3 of 9 children without BCG scars (33.3%) had osteomyelitis. Our observations support the conclusion that having a BCG vaccination scar provides significant protection against M. ulcerans osteomyelitis in children with BU disease.
Portaels
F
F
Department of Microbiology, Institute of Tropical Medicine, 2000 Antwerp, Belgium. portaels@itg.be
Aguiar
J
J
Debacker
M
M
Steunou
C
C
Zinsou
C
C
Guédénon
A
A
Meyers
W M
WM
D001500:BCG Vaccine / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D009165:Mycobacterium Infections, Nontuberculous / Q000517:prevention & control*; D019911:Mycobacterium ulcerans; D010019:Osteomyelitis / Q000517:prevention & control*; D014611:Vaccination
D001500:BCG Vaccine